Also trades as: 2137.HK (HKSE) · $vol 0M
BRIBF OTC
Brii Biosciences Limited
1W: +0.0%
1M: +0.0%
3M: -13.0%
YTD: -30.4%
1Y: -46.0%
3Y: -89.6%
$0.13
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$2.4B
-12.8% ▼
5Y CAGR: +13.2%
Total Liabilities
$36M
-64.0% ▼
5Y CAGR: -58.7%
Shareholders Equity
$2.4B
-10.5% ▼
Cash & Investments
$1.9B
-16.3% ▼
5Y CAGR: +13.0%
Total Debt
$9M
-68.1% ▼
5Y CAGR: -20.6%
Net Debt
-$600M
+38.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.9B | $1.2B | $490M | $1.0B | $609M |
| Short-Term Investments | $500M | $1.8B | $2.2B | $1.3B | $1.3B |
| Cash & ST Investments | $3.4B | $3.0B | $2.7B | $2.3B | $1.9B |
| Net Receivables | $6M | $12M | $17M | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $53M | $68M | $54M | $75M | $22M |
| Total Current Assets | $3.4B | $3.1B | $2.8B | $2.4B | $2.0B |
| Property, Plant & Equip. | $33M | $20M | $6M | $14M | $14M |
| Goodwill & Intangibles | $10M | $147M | $267M | $180M | $298M |
| Long-Term Investments | -$348M | -$1.7B | -$2.0B | -$1.3B | $7M |
| Other Non-Current Assets | $502M | $149M | $2.2B | $1.4B | $77M |
| Total Non-Current Assets | $198M | $315M | $415M | $293M | $397M |
| Total Assets | $3.6B | $3.4B | $3.2B | $2.7B | $2.4B |
| — Liabilities — | |||||
| Accounts Payable | $0 | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $5M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$6M | -$82M | $62M | $27M | $14M |
| Total Current Liabilities | $281M | $229M | $126M | $77M | $32M |
| Long-Term Debt | $0 | $0 | $0 | $18M | $0 |
| Other Non-Current Liab. | $7M | $2M | $0 | $0 | $0 |
| Total Non-Current Liabilities | $20M | $5M | $0 | $23M | $4M |
| Total Liabilities | $300M | $234M | $126M | $101M | $36M |
| — Equity — | |||||
| Common Stock | $23K | $24K | $24K | $24K | $24K |
| Retained Earnings | -$6.0B | -$6.5B | -$6.7B | -$7.2B | $0 |
| Accumulated OCI | $64M | $365M | $439M | $0 | $0 |
| Total Stockholders Equity | $3.3B | $3.2B | $3.1B | $2.7B | $2.4B |
| Total Liabilities & Equity | $3.6B | $3.4B | $3.2B | $2.7B | $2.4B |
| — Key Metrics — | |||||
| Total Debt | $22M | $13M | $3M | $28M | $9M |
| Net Debt | -$2.8B | -$1.2B | -$486M | -$975M | -$600M |
| Total Investments | $152M | $146M | $142M | $9M | $1.3B |